mRNAワクチンに対するB細胞反応の生殖中心駆動成熟
Wooseob Kim1, Julian Q Zhou1, Stephen C Horvath1
1Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Nature
|February 15, 2022
まとめ
SARS-CoV-2 mRNA ワクチン接種は,長期間続く生殖中心の反応を誘発し,ワクチン接種後6ヶ月間,ウイルスを中和させる非常に効果的な,親和性成熟した抗体につながります.
科学分野:
- 免疫学
- ワクチン学
- 分子生物学
背景:
- ゲルミナルセンター (GC) は,記憶B細胞 (MBCs) と長寿骨髄プラズマ細胞 (BMPCs) を生成するB細胞の親和性成熟に不可欠です.
- SARS-CoV-2 mRNAワクチン接種は,少なくとも6ヶ月持続するヒトのGC反応を誘発する.
- ワクチン接種後のGCB細胞の長期的命運と機能的影響は不明である.
研究 の 目的:
- mRNAワクチン接種後のSARS-CoV-2スペイク特有のB細胞クローンの進化と機能的結果を調査する.
- SARS-CoV-2 mRNAワクチン接種によって生成されたメモリB細胞とプラズマ細胞の特徴を決定する.
- 抗体アビディティと中和能力に対する体性高変異の蓄積の影響を評価する.
主な方法:
- 血のプラズマブラスト,MBC,リンパ節のGCB細胞,BMPCからのB細胞受容体の配列決定
- BMPCクローンから派生したモノクローン抗体の発現と特徴づけ
- ソマティック・ハイパーミューテーション (SHM) 頻度と抗体アビデンス測定の定量化.
主要な成果:
- SARS-CoV-2 mRNAワクチン接種は,GC B細胞のSHM頻度が6ヶ月間にわたって増加する持続的なGC反応を誘発した.
- スパイク特有のMBCsとBMPCsは,抗体アビディティの強化と相関する,有意なSHMを蓄積した.
- BMPCからのモノクローナル抗体は,SARS-CoV-2に対する親和性と強力な中和能力を示した.
結論:
- SARS-CoV-2 mRNAワクチン接種の後の持続的なGC反応は,親和性と中和性の強化による長期の抗体反応につながります.
- この研究は,抗体反応の成熟過程を明らかにし,持続的なウイルス保護に不可欠である.
- この発見は,mRNAワクチンによる持続的な免疫の効果を強調しています.
関連する概念動画
B Cell Activation and Differentiation
8.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
8.5K
Cells of the Adaptive Immune Response
5.3K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
5.3K
Vaccinations
45.6K
Overview
45.6K
Diversity of Antigen Receptors
877
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
877
Cell-mediated Immune Responses
74.8K
Overview
74.8K
Development of Immunocompetence
484
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
484


